Test Results For:

Glycosylated Hemoglobin (HbA1c)

Test Name

Glycosylated Hemoglobin (HbA1c)

Test Code

HBA1C

Short Description

HBA1C

Test Name

Glycosylated Hemoglobin (HbA1c)

Test Code

HBA1C

Category

Biochemistry

TAT

Main Lab: 6 Hour(s)
Family Site: <8hrs

Specimen(s)

1 x Venous blood - 4000 mL Tube - Lavender - EDTA HbA1c

Specimen Type

EDTA HbA1c

Specimen Format

Tube

Specimen Colour

Lavender

Specimen Volume

4000 mL

Sampling Order

4

Origin

Venous blood

Collection Time after baseline

-

Transport Temperature

15-25°C

Accepted Other Specimens

EDTA Whole Blood

TAT

Main Lab: 6 Hour(s)
Family Site: <8hrs

Test Stability

Room Temp: 3 Day(s)
2–8°C: 7 Day(s)

Methodology

Capillary electrophoresis

Specimen Type

EDTA HbA1c

Other Type of Specimen Accepted

EDTA Whole Blood

Delay before pre-treatment

-

Transport temperature

15-25°C

Test stability at room temperature

3 Day(s)

Test stability at 2–8°C

7 Day(s)

Haemolysis interference

No

Methodology

Capillary electrophoresis

Specimen Type

EDTA HbA1c

Other Type of Specimen Accepted

EDTA Whole Blood

Delay before pre-treatment

-

Transport temperature

15-25°C

Test stability at room temperature

3 Day(s)

Test stability at 2–8°C

7 Day(s)

Haemolysis interference

No

Methodology

Calculation

Specimen Type

EDTA HbA1c

Other Type of Specimen Accepted

EDTA Whole Blood

Delay before pre-treatment

-

Transport temperature

15-25°C

Test stability at room temperature

3 Day(s)

Test stability at 2–8°C

7 Day(s)

Haemolysis interference

No

Methodology

-

Specimen Type

EDTA HbA1c

Other Type of Specimen Accepted

EDTA Whole Blood

Delay before pre-treatment

-

Transport temperature

15-25°C

Test stability at room temperature

3 Day(s)

Test stability at 2–8°C

7 Day(s)

Haemolysis interference

No


Clinical Interest

HbA1c is used in the diagnosis of diabetes and prediabetes. It reflects average blood glucose levels over the past 2-3 months, providing a more stable and reliable measure compared to daily glucose monitoring. It's particularly useful for monitoring long-term glycemic control in diabetic patients.

For individuals with diabetes, HbA1c levels serve as a marker of average blood glucose levels over time. Regular monitoring helps healthcare providers assess the effectiveness of treatment plans and make adjustments as necessary to achieve target levels and prevent complications.

Elevated HbA1c levels are associated with an increased risk of diabetes-related complications such as cardiovascular disease, nephropathy, retinopathy, and neuropathy. Monitoring HbA1c levels helps identify patients at higher risk of developing these complications and allows for early intervention to prevent or delay their onset.

HbA1c levels guide treatment decisions in diabetes management. Lowering HbA1c levels through lifestyle changes, medication adjustments, and other interventions reduces the risk of long-term complications and improves overall health outcomes.

Clinical Information Required

Insulin Therapy


Patient Collection Note

-

LOINC Code

48-4, 4548-4

Outwork

No

Notification just now
URL copied to clipboard.
Find a Lab Now

Cerba Lancet Africa on the continent

Botswana Eswatini Ethiopia Gabon Ghana Ivory Coast Kenya Mozambique Nigeria Rwanda Tanzania Uganda Zambia Zimbabwe